NCT03877562 - The Effect of CORT118335 on Olanzapine-Induced Weight Gain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

March 13, 2020

Study Completion Date

March 25, 2020

Conditions

Antipsychotic-induced Weight Gain

Interventions

DRUG

Olanzapine

Olanzapine 10 mg oral tablet

DRUG

CORT118335

CORT118335 600 mg oral tablets administered as 2 X 300 mg or 6 X 100 mg tablets

DRUG

Placebo

Placebo matching CORT118335, 2 or 6 oral tablets, depending on the CORT118335 tablet strength available

Trial Locations (1)

Quotient Sciences, Ruddington